Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Carcinoma, Renal Cell 13 Kidney Neoplasms 4 Uterine Cervical Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Neuroendocrine Tumors 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Cystadenocarcinoma, Serous 1 Clear-cell metastatic renal cell carcinoma 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Advanced Renal Cell Carcinoma (RCC) 1 Advanced Non-small Cell Lung Cancer 1

Interventions

Dexamethasone 114 daratumumab 68 Lenalidomide 66 Bortezomib 55 pomalidomide 44 carfilzomib 39 Cyclophosphamide 33 Specimen Handling 30 Calcium Dobesilate 30 Biopsy 27 Magnetic Resonance Spectroscopy 24 belantamab mafodotin 20 isatuximab 19 fludarabine 17 talquetamab 16 iberdomide 15 Melphalan 15 dexamethasone acetate 13 dexamethasone 21-phosphate 13 auricularum 13 fludarabine phosphate 11 selinexor 10 elotuzumab 10 tocilizumab 9 X-Rays 8 Nivolumab 8 Sirolimus 7 trametinib 6 Whole-Body Irradiation 6 Mycophenolic Acid 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Axitinib × 90 days × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡